161 related articles for article (PubMed ID: 36689813)
21. MATR3 mutation analysis in a Chinese cohort with sporadic amyotrophic lateral sclerosis.
Xu L; Li J; Tang L; Zhang N; Fan D
Neurobiol Aging; 2016 Feb; 38():218.e3-218.e4. PubMed ID: 26708275
[TBL] [Abstract][Full Text] [Related]
22. Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing.
Banerjee A; Vest KE; Pavlath GK; Corbett AH
Nucleic Acids Res; 2017 Oct; 45(18):10706-10725. PubMed ID: 28977530
[TBL] [Abstract][Full Text] [Related]
23. ALS Associated Mutations in Matrin 3 Alter Protein-Protein Interactions and Impede mRNA Nuclear Export.
Boehringer A; Garcia-Mansfield K; Singh G; Bakkar N; Pirrotte P; Bowser R
Sci Rep; 2017 Nov; 7(1):14529. PubMed ID: 29109432
[TBL] [Abstract][Full Text] [Related]
24. Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype.
Moloney C; Rayaprolu S; Howard J; Fromholt S; Brown H; Collins M; Cabrera M; Duffy C; Siemienski Z; Miller D; Swanson MS; Notterpek L; Borchelt DR; Lewis J
Acta Neuropathol Commun; 2016 Nov; 4(1):122. PubMed ID: 27863507
[TBL] [Abstract][Full Text] [Related]
25. MATR3 pathogenic variants differentially impair its cryptic splicing repression function.
Khan M; Chen XXL; Dias M; Santos JR; Kour S; You J; van Bruggen R; Youssef MMM; Wan YW; Liu Z; Rosenfeld JA; Tan Q; Pandey UB; Yalamanchili HK; Park J
FEBS Lett; 2024 Feb; 598(4):415-436. PubMed ID: 38320753
[TBL] [Abstract][Full Text] [Related]
26. Generation and characterization of a human iPSC line from an ALS patient carrying the Q66K-MATR3 mutation.
Pollini D; Loffredo R; Cardano M; Conti L; Lattante S; Notarangelo A; Sabatelli M; Provenzani A
Stem Cell Res; 2018 Dec; 33():146-150. PubMed ID: 30366341
[TBL] [Abstract][Full Text] [Related]
27. MATR3's Role beyond the Nuclear Matrix: From Gene Regulation to Its Implications in Amyotrophic Lateral Sclerosis and Other Diseases.
Santos JR; Park J
Cells; 2024 Jun; 13(11):. PubMed ID: 38891112
[TBL] [Abstract][Full Text] [Related]
28. Matrin 3 in neuromuscular disease: physiology and pathophysiology.
Malik AM; Barmada SJ
JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33427209
[TBL] [Abstract][Full Text] [Related]
29. MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy.
Runfola V; Giambruno R; Caronni C; Pannese M; Andolfo A; Gabellini D
Cell Rep; 2023 Sep; 42(9):113120. PubMed ID: 37703175
[TBL] [Abstract][Full Text] [Related]
30. Duplication of exons 15 and 16 in Matrin-3: a phenotype bridging amyotrophic lateral sclerosis and immune-mediated disorders.
Caputo M; Zucchi E; Martinelli I; Gianferrari G; Simonini C; Amedei A; Niccolai E; Gellera C; Pensato V; Mandrioli J
Neurol Sci; 2022 Feb; 43(2):1419-1421. PubMed ID: 34665352
[TBL] [Abstract][Full Text] [Related]
31. The role of Matrin-3 in physiology and its dysregulation in disease.
Sprunger ML; Jackrel ME
Biochem Soc Trans; 2024 Jun; 52(3):961-972. PubMed ID: 38813817
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity of Matrin 3 in the developing and aging murine central nervous system.
Rayaprolu S; D'Alton S; Crosby K; Moloney C; Howard J; Duffy C; Cabrera M; Siemienski Z; Hernandez AR; Gallego-Iradi C; Borchelt DR; Lewis J
J Comp Neurol; 2016 Oct; 524(14):2740-52. PubMed ID: 26878116
[TBL] [Abstract][Full Text] [Related]
33. Molecular determinants and modifiers of Matrin-3 toxicity, condensate dynamics, and droplet morphology.
Sprunger ML; Lee K; Sohn BS; Jackrel ME
iScience; 2022 Mar; 25(3):103900. PubMed ID: 35252808
[TBL] [Abstract][Full Text] [Related]
34. A novel Arg147Trp MATR3 missense mutation in a slowly progressive ALS Italian patient.
Origone P; Verdiani S; Bandettini Di Poggio M; Zuccarino R; Vignolo M; Caponnetto C; Mandich P
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):530-1. PubMed ID: 26199109
[No Abstract] [Full Text] [Related]
35. MATR3-antisense LINE1 RNA meshwork scaffolds higher-order chromatin organization.
Zhang Y; Cao X; Gao Z; Ma X; Wang Q; Xu X; Cai X; Zhang Y; Zhang Z; Wei G; Wen B
EMBO Rep; 2023 Aug; 24(8):e57550. PubMed ID: 37381832
[TBL] [Abstract][Full Text] [Related]
36. MATR3 disruption in human and mouse associated with bicuspid aortic valve, aortic coarctation and patent ductus arteriosus.
Quintero-Rivera F; Xi QJ; Keppler-Noreuil KM; Lee JH; Higgins AW; Anchan RM; Roberts AE; Seong IS; Fan X; Lage K; Lu LY; Tao J; Hu X; Berezney R; Gelb BD; Kamp A; Moskowitz IP; Lacro RV; Lu W; Morton CC; Gusella JF; Maas RL
Hum Mol Genet; 2015 Apr; 24(8):2375-89. PubMed ID: 25574029
[TBL] [Abstract][Full Text] [Related]
37. Retraction Note: Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype.
Moloney C; Rayaprolu S; Howard J; Fromholt S; Brown H; Collins M; Cabrera M; Duffy C; Siemienski Z; Miller D; Swanson MS; Notterpek L; Borchelt DR; Lewis J
Acta Neuropathol Commun; 2017 Dec; 5(1):97. PubMed ID: 29237481
[TBL] [Abstract][Full Text] [Related]
38. Stress granules at the intersection of autophagy and ALS.
Monahan Z; Shewmaker F; Pandey UB
Brain Res; 2016 Oct; 1649(Pt B):189-200. PubMed ID: 27181519
[TBL] [Abstract][Full Text] [Related]
39. The heterozygous R155C VCP mutation: Toxic in humans! Harmless in mice?
Clemen CS; Winter L; Strucksberg KH; Berwanger C; Türk M; Kornblum C; Florin A; Aguilar-Pimentel JA; Amarie OV; Becker L; Garrett L; Hans W; Moreth K; Neff F; Pingen L; Rathkolb B; Rácz I; Rozman J; Treise I; Fuchs H; Gailus-Durner V; de Angelis MH; Vorgerd M; Eichinger L; Schröder R
Biochem Biophys Res Commun; 2018 Sep; 503(4):2770-2777. PubMed ID: 30100055
[TBL] [Abstract][Full Text] [Related]
40. Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS.
Kamelgarn M; Chen J; Kuang L; Arenas A; Zhai J; Zhu H; Gal J
Biochim Biophys Acta; 2016 Oct; 1862(10):2004-14. PubMed ID: 27460707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
